Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death worldwide, and the mortality of patients with PDAC has not significantly decreased over the last few decades. Novel strategies exhibiting promising effects in preclinical or phase I/II clinical trials are oft...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Jiali, Gu, Jichun, Li, Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396420/
https://www.ncbi.nlm.nih.gov/pubmed/32677676
http://dx.doi.org/10.1042/BSR20200401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396420/
https://www.ncbi.nlm.nih.gov/pubmed/32677676
http://dx.doi.org/10.1042/BSR20200401

Ejemplares similares